Scabies: Burrow Recognition, Permethrin-Ivermectin Cascades & Crusted Outbreak Vigil

Scabies describes infestation of the epidermis by the obligate ectoparasite Sarcoptes scabiei var. hominis. Female mites tunnel within the stratum corneum, deposit eggs and antigenic fecal pellets (scybala), provoking a predominantly T-helper-1 hypersensitivity reaction in sensitised hosts. Typical burdens range from roughly 10–15 mites in healthy immunocompetent people, yet symptoms can still dominate because of robust inflammatory signalling; re-infestation after prior sensitisation usually produces pruritus within days rather than the 4–8 week delay following first exposure.

Transmission usually requires sustained skin-to-skin contact such as co-sleeping, nursing care, sexual activity or rough-and-tumble play in children. Fomite spread is uncommon in classic scabies but becomes relevant with crusted disease when environmental surfaces and bedding may harbour large numbers of mites. WHO recognises scabies as a neglected tropical disease with disproportionate morbidity in overcrowded, low-resource and humanitarian settings, where secondary pyoderma can drive downstream renal and soft-tissue complications.

From a nursing workflow perspective, scabies sits at the intersection of accurate cutaneous inspection, choreographed mass treatment of contacts, meticulous medication teaching, and infection-prevention reflexes when crusted cases appear on vulnerable wards. Miss any one layer and the same patient returns with “treatment failure” that is really partial treatment or reinfection.

Mapping phenotype early determines therapy intensity, isolation level and how aggressively you pursue environmental control.

↔On a small screen, swipe or scroll sideways to see the full table.

Many patients present with itch out of proportion to subtle exam findings—especially after partial topical steroid use—so history of nocturnal worsening, identical symptoms in co-sleepers and recent shelter, residential care or sexual network exposure should be captured before you anchor on a benign “winter dry skin” label.

Typical features

• Generalised pruritus worse at night or after hot showers; sleep disruption is a common chief complaint.
• Symmetric papules, vesicles and linear excoriations along beltline, axillae, anterior thighs, male genitalia and female breast areolae.
• Pathognomonic burrows: thin greyish serpiginous lines with a terminal black speck (mite) best seen on wrists, web spaces, palms and feet in young children.
• Infants, older adults and people with neurologic impairment may show scalp, face, palm and sole involvement more often than healthy adults.

Atypical or masked pictures

• “Scabies incognito” after unsupervised potent topical steroids—diffuse eczematous change with few primary lesions.
• Isolated nodules without obvious burrows in adolescents and young adults.
• Predominant rash on trunk with minimal peripheral signs in heavily pigmented skin—rely on contact history and dermoscopy rather than erythema intensity.
• Crusted scabies with minimal pruritus but malodorous scale—high suspicion in nursing-home residents with dementia.

The mite lifecycle is entirely human-hosted; pets do not transmit human scabies. Risk reflects behaviours and environments that prolong skin contact or depress immunity.

Non-modifiable / structural risks

• Age extremes with frequent handling (infants) or dependence on personal care (frail aged care recipients).
• Immunosuppression: HIV, transplant therapy, biologics, chronic steroids—especially drives crusted phenotype.
• Humanitarian crises, prison crowding, mass shelters—settings where mass drug administration may be led by public health.

Modifiable levers

• Delaying treatment of intimate partners or overnight visitors—reinfection loop.
• Sharing unwashed bedding or clothing within 3 days in crusted cases.
• Inadequate application technique (skipping soles, web spaces, retro-auricular folds, under nails).

Diagnosis remains clinical in most frontline settings, but the 2020 International Alliance for the Control of Scabies (IACS) framework stratifies certainty into confirmed (mite products visualised), clinical and suspected categories—useful language for notes, public-health reporting and medico-legal clarity.

Bedside assessment

• Full skin assessment with good light; examine interdigital webs, waistband, areolae and genitalia with chaperoning per policy.
• Dermoscopy when available—may highlight delta-wing jet sign at burrow entry.
• Review contacts: who shares a bed, provides personal care or has identical itch timeline?

Laboratory confirmation (when ambiguous)

• Superficial skin scrape from burrow roof placed on glass slide with saline or potassium hydroxide—light microscopy by trained staff.
• Skin punch biopsy reserved for atypical nodular or bullous cases where histology aids exclude mimics.
• Send wound culture when purulent drainage, cellulitic spread or inpatient sepsis risk—guides antistaphylococcal/streptococcal add-ons.

No routine imaging

Imaging does not aid diagnosis unless you are investigating unrelated complications (e.g. osteomyelitis from neglected cellulitis).

1. Stratify certainty. Burrows + classic distribution + contacts symptomatic → treat without waiting for microscopy if clinical risk-benefit supports action.
2. Choose vehicle. Immunocompetent outpatient with intact skin → overnight permethrin day 0 and 7–14; adherence or body-surface challenges → consider oral ivermectin days 0 and 7–14 with prescriber oversight.
3. Bundle contacts. Dispense or schedule treatment for entire household and sexual network the same night; document who declined and safety-net.
4. Environment. Hot wash/dry ≥60 °C or seal 72 h–7 d for items contacting skin in prior 3 days; intensify for crusted cases.
5. Reassess at 2–4 weeks. Improving inflammation with no new burrows → continue symptomatic relief. New lesions → evaluate for partial treatment, resistance (rare) or untreated contact.
6. Escalate crusted pathway. Combine topical keratolytics plus multiple ivermectin doses, involve infectious diseases, continue precautions until two negative supervised scrapes or protocol-based clearance.

↔On a small screen, swipe or scroll sideways to see the full table.

Therapeutic goals: eradicate mites, interrupt household transmission, manage secondary infection, and document IPC steps for crusted cases. Always align with local formulary, pregnancy category and paediatric licensing.

First-line topical therapy

• 5% permethrin cream applied to cool dry skin from neck down in adults; include scalp, face, ears, palms, soles and nails in infants and when national guidance mandates—avoid eyes and mucosa.
• Leave 8–14 hours (usually overnight), wash off, repeat at day 7–14 to kill newly hatched larvae.
• Reapply to hands if washed during treatment window; trim nails and brush under nail plates before application.

Systemic therapy

• Oral ivermectin 200 micrograms/kg (two doses 7–14 days apart) for classic scabies when topical therapy impractical, crusted scabies regimens, or outbreaks—check local pregnancy/breastfeeding rules.
• Crusted cases often need >2 doses plus keratolytics and prolonged precautions; coordinate with specialist teams.

Alternatives / resource-limited contexts

• 10–25% benzyl benzoate emulsion, 0.5% malathion aqueous lotion, topical sulfur ointment (often 5–10%) where permethrin unavailable—irritation more common; still repeat per local protocol.
• Mass drug administration strategies belong to public-health programmes—do not improvise without supervision.

Adjuncts

• Oral antihistamines or moderate-potency topical steroids for post-scabetic itch after antiparasitic completion—not as monotherapy for active mites.
• Treat bacterial superinfection using local acute skin infection guidance while maintaining scabicide schedule.

Pregnancy and breastfeeding

Permethrin is generally favoured in pregnancy (category context per local label); oral ivermectin typically avoided in first trimester unless specialist-directed. Document shared decision conversations.

Infants & children

Include hairline, scalp, palms and soles; weight-band ivermectin only when formally prescribed; watch for toxicity if accidental licking of product—use mittens after application if age-appropriate.

Immunocompromised / HIV

Lower threshold for crusted disease; consider prolonged regimens, screen for secondary sepsis, involve infectious diseases early.

Residential aged care

Outbreak kits, cohorting, staff symptom surveys, laundering of lift chairs and therapy equipment—chart each step for regulators.

• Teaching loop: use teach-back for “whole body once, overnight, repeat in one week”; give written diagrams in the patient’s language.
• Medication reconciliation: capture prior ivermectin (e.g. community parasite campaigns) via medication reconciliation to prevent duplicate dosing.
• Specimen handling: when scraping, follow specimen collection workflows so slides reach lab within fixative windows.
• Stigma-sensitive counselling: frame infestation as common and unrelated to cleanliness; offer discrete pharmacy routing.
• Return-to-work/education timing: align with CDC or national advice—typically after first effective treatment unless extensive crusting or open drainage mandates longer exclusion.
• Wound interplay: coordinate emollients and open erosions through wound care principles to minimise secondary infection.

Vitals and systemic surveillance

• Track temperature and NEWS where policy demands—rising fever with erythema may signal cellulitis or bacteraemia, not “just itch”.
• Photos or tracing of lesion extent at admission/discharge to objectify improvement.

IPC checklist for classic vs crusted

• Classic: standard plus contact precautions until 24 h after first scabicide or per local rule; linen in alginate bags; dedicated wash cloths.
• Crusted: add airborne/contact bundle, single room, dedicated equipment, terminal clean with environmental services, staff prophylaxis per occupational health.
• Audit hand hygiene on entry/exit; patients may psychologically over-use alcohol gel—reinforce emollients to prevent irritant dermatitis.

Red flags during treatment

• New burrows after two properly timed doses—search for untreated contact or institution outbreak.
• Spiking fevers, rigors or hypotension—invoke sepsis screening.
• Painful purulent plaques—upgrade bacterial coverage after cultures.

• Secondary impetigo and cellulitis from Staphylococcus aureus or Streptococcus pyogenes.
• Post-streptococcal glomerulonephritis in endemic pyoderma belts—urine dip and BP follow-up when GAS superinfection documented.
• Insomnia, anxiety and relationship strain from misinformation or perceived stigma.
• Irritant dermatitis from repeated permethrin courses or excessive environmental disinfectant use.

Primary prevention in facilities hinges on early recognition, fast mass treatment, staff education and environmental mitigation. Secondary prevention means tracing contacts for 4–8 weeks prior to symptom onset where feasible.

• Maintain line lists for dormitories, shelters and nursing units; align with CDC institutional scabies control guidance when designing bundle elements.
• Reinforce that pets do not require treatment for human scabies—redirect resources to human contacts.

With complete treatment and simultaneous contact coverage, classical scabies resolves without sequelae; post-scabetic itch can mislead families but usually trends down over 2–6 weeks. Crusted scabies carries higher morbidity, longer hospitalisation and measurable mortality risk through secondary sepsis—prognosis ties to rapid IPC response and immunologic recovery.

Patients often blame themselves or fear job loss—begin with normalising language, then translate permethrin steps into concrete routines (“apply after dinner, Netflix, then sleep in old pyjamas you will hot-wash tomorrow”). Watch for safeguarding and intimate partner violence triggers when infestation recurs despite education; collaborate with social work discreetly.

Bedside checklist

• Who slept in the bed in the past month—list names, not vague “partner”.
• Did every named person receive medication tonight? Document no-shows.
• Are cream tubes enough for weight/surface area? Order two if needed.
• Follow-up call at day 10–14 to confirm second dose.

Initial actions: ABC assessment, IV access if indicated, blood cultures before antibiotics when feasible, early senior + infectious-disease input, continue scabicide plan once stable, trigger rapid response activation per local criteria.

Nursing-priority lens (NCSBN Clinical Judgment Measurement Model): recognise cues → analyse cues → prioritise hypotheses → generate solutions → take safe action → evaluate outcomes. These questions are written in an NCLEX-style format to support nursing clinical judgment. They are educational examples, not official NCSBN exam items.